Health
New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2 – News-Medical.Net
In a groundbreaking bioRxiv study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-C…
In a groundbreaking bioRxiv* study, US researchers demonstrate the capability of next-generation bivalent human adenovirus serotype 5 (hAd5) vaccine for inducing both cellular and humoral immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – using both an S protein sequence optimized for cell surface expression and a conserved nucleocapsid antigen designed to be transported to the endosomal subcellular compartment.
In response to the ongoing health crisis brought by th…
-
General23 hours agoFederal government funding extends cohealth GP services until July 2026
-
General7 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
Noosa News21 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General10 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique